All Activity

This sounds like a fantastic event! It's great to see a conference focusing on womxn in the cannabis and psychedelic industries. The agenda looks packed with insightful discussions, especially the panel on compliant marketing – a crucial topic as the industry evolves. My own Granny used cannabis oil for pain management later in life, so I truly appreciate the focus on wellness and patient insights. Hoping this conference helps break down stigmas and empowers more women in the field!

A bipartisan coalition of 32 members of Congress is urging federal health officials to expedite ongoing reviews of psychedelic therapies. “For many individuals, current treatment options remain insufficient, deepening an already urgent public health crisis,” the lawmakers, led by Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, wrote in a letter to the head of the Food and Drug Administration (FDA). “As Members of the House of Representatives, we have heard from countless Veterans, clinicians, and families seeking evidence-based alternatives.” The letter to FDA Commissioner Marty Makary says lawmakers are “encouraged” by his recent statement that psychedelic treatments are “a top priority for this FDA and this administration.” FDA and the Department of Health and Human Services (HHS) last month announced steps that they say will help with “accelerating” therapeutic access to psychedelics for patients dealing with serious mental health conditions. That move followed a psychedelics executive order that President Donald Trump signed. The lawmakers’ new letter said they want FDA to pursue “‘an expeditious and rapid review’ of promising treatments, especially those that address urgent unmet needs in PTSD, traumatic brain injury, and other neuropsychiatric conditions”—but they also “understand and respect the agency’s role in ensuring that any new treatment meets rigorous standards of safety and efficacy.” They said that recent developments, including the public release of documents related to the rejection of approval for MDMA-assisted therapy during the Biden administration “highlight the complexity of evaluating innovative treatment modalities and underscore the need for clear, consistent expectations for this emerging field.” The lawmakers have a number of questions they want Makary to answer: Special Protocol Assessment (SPA): How does the FDA communicate and apply any remaining data concerns beyond clearly defined primary endpoints and control conditions when pivotal trials are conducted under an SPA? Are improvements underway to make regulatory expectations more predictable for therapies in emerging fields? Methodological Standards and Interagency Coordination: What steps is the FDA taking to clarify methodological expectations for entactogen- and psychedelic-assisted clinical trials—including strategies to mitigate functional unblinding and expectancy effects—and how is the agency coordinating with federal partners such as the U.S. Department of Veterans Affairs to streamline research pathways for populations with urgent unmet needs, including Veterans with PTSD. Review Integrity and Subject-Matter Expertise: How does the FDA ensure that qualified experts with relevant experience conduct reviews of entactogen- and psychedelic-assisted therapies? What steps are in place to ensure consistency, objectivity, and independence in the evaluation process? Final Guidance Timeline: What is the expected timeline for finalizing the FDA’s June 2023 guidance on clinical trials involving rapid-acting novel therapeutics, including entactogen- and psychedelic-assisted therapies? They are also encouraging FDA to provide clarity in any new guidance concerning: Strategies to mitigate functional unblinding and expectancy bias; Standards for adverse event monitoring and safety reporting; Provider training, licensing, and participant safeguards; The evolving role of psychotherapy in conjunction with pharmacological intervention; Generalizability of findings across diverse patient populations; and Consistency in regulatory expectations across entactogen and psychedelic drug development programs. “We remain committed to ensuring that Veterans and others living with treatment-resistant mental health conditions have access to safe, evidence-based care,” the lawmakers wrote. “We respectfully urge the FDA to continue its evaluation of entactogen- and psychedelic-assisted therapies with transparency, urgency, and scientific rigor as the agency carries out its statutory responsibilities.” In addition to Bergman and Correa, other lawmakers who signed the letter include Reps. Dan Crenshaw (R-TX), Morgan Luttrell (R-TX), Pete Sessions (R-TX), Alexandria Ocasio-Cortez (D-NY), Nancy Mace (R-SC), Mark Pocan (D-WI), Mariannette Miller-Meeks (R-IA) and Derrick Van Orden (R-WI). HHS Secretary Robert F. Kennedy Jr. said recently that the Trump administration is “very anxious” to create a pathway for access to psychedelics therapy and that top officials across federal agencies want to “get it out to the public as quickly as possible.” In an interview on the Joe Rogan Experience in February, Kennedy said he’s confident “we’re going to get it done,” with plans to develop and finalize rules that would enable patients with conditions such as post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled setting.” “Everybody in my agency…is very anxious to get a rule out there that will allow these kind of studies and will allow access under therapeutic settings, particularly [for] the military soldiers who have suffered these injuries to get access to these products,” the HHS secretary said. “We’re working through that process now. We’re all working on it and trying to make it happen.” “I think that we’re going to get it done,” he said. Last June, Kennedy said his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans “within 12 months.” Veterans Affairs Secretary Doug Collins also disclosed in April that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access. Bipartisan congressional lawmakers introduced legislation this session to provide $30 million in funding annually to establish psychedelic-focused “centers for excellence” at U.S. Department of Veterans Affairs (VA) facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine. A U.S. Senate committee held a hearing last month on a bipartisan bill to promote research into the therapeutic potential psychedelics by creating a new office at VA that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and MDMA. Former U.S. House Speaker Newt Gingrich (R-GA) has said ibogaine represents an “astonishing breakthrough” in the nation’s current “sick care system” that’s left people with serious mental health conditions without access to promising alternative treatment options. The post Bipartisan Lawmakers Push FDA To Speed Up Approval Of Psychedelic Therapies appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A bill that would allow California marijuana stores to offer drive-thru windows to serve customers is heading to a floor vote in the state Assembly. The measure, which cleared the Assembly Appropriations Committee in a 13-1 vote on Wednesday, says that licensed cannabis retailers and microbusinesses with storefronts could sell marijuana products “to a customer in a motor vehicle in a drive-through located on the premises.” Under AB 2697 from Assemblymember Gail Pellerin (D), which last month was approved by the Assembly Business and Professions Committee, cannabis businesses would need approval from the local jurisdictions in which they operate in order to add the drive-thru option. Assemblymember Jessica Caloza (D) told colleagues before the most recent vote that the bill will address a “regulatory inconsistency” under which “licensed cannabis retailers can offer curbside pickup as a remnant of COVID pandemic adaptations” but “generally cannot fulfill orders for customers sitting in their car at a drive-thru.” The legislation would “make legal cannabis more accessible and will help the legal market compete with illicit market,” she said. Mark Smith of Chuck’s Wellness Center, a retailer in Placerville, said the bill is “about improving access.” “A significant portion of customers rely on cannabis as medicine, including seniors, veterans and individuals living with chronic conditions that affect mobility—exactly the population this regulated system is meant to serve,” he said. “For many, even simple tasks like exiting a vehicle and navigating a retail space can be physically difficult or prohibitive.” “A drive-thru model addresses this gap in a controlled, compliant manner,” Smith said. “It reduces physical barriers, supports [Americans With Disabilities Act]-conscious principles and creates a more inclusive retail environment without changing who has access—only how that access is provided.” Amy O’Gorman Jenkins of the California Cannabis Operators Association said the proposal “supports the fiscal interests of the state at a time when you see cannabis revenues in sharp decline.” “Anything we can do to offer practical solutions to keep consumers in our stores is really, really important,” she said. The bill next heads to an Assembly floor vote before potentially going to the Senate for consideration. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — California regulators recently adopted changes to the state’s marijuana licensing process that are intended to make it easier for businesses to qualify for benefits in line with the Trump administration’s recent move to federally reschedule medical cannabis. Gov. Gavin Newsom (D), meanwhile, recently took credit for helping to lead the push for the state to legalize marijuana and discussed his own limited experience with using cannabis. In October, however, Newsom vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.” Newsom did sign a bill earlier that month aimed at streamlining research on marijuana and psychedelics. In September, the governor also signed a measure into law to put a pause on a recently enacted tax hike on marijuana products. California officials recently awarded nearly $30 million in grants for marijuana-focused academic research projects. Photo courtesy of Mike Latimer. The post California Bill To Allow Drive-Thrus At Marijuana Dispensaries Advances To Assembly Floor Vote appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A single dose of psilocybin, coupled with psychotherapy, appears to be a “safe and efficacious” treatment option for people with cocaine use disorders (CUD), according to a new study published by the American Medical Association (AMA). The findings about the psychedelic, published in JAMA Substance Use and Addiction on Thursday, are especially promising given that “no medications have been proven effective” in the treatment of CUD. Psilocybin-assisted therapy could represent a solution to that “elusive” problem, researchers at the University of Alabama, Johns Hopkins University and the Karolinska Institute found. For the randomized, quadruple-blind, placebo-controlled clinical trial, 36 participants who met the diagnostic criteria for cocaine use disorder were screened and received psychotherapy incorporating cognitive-behavioral treatment one month before and one month after an “all-day investigational drug treatment session” with psilocybin. During the medication session, participants were randomly assigned either 25 mg of psilocybin per kilogram of body weight or a placebo. Researchers found that, compared to the placebo group, “psilocybin-treated participants showed significantly greater percentages of cocaine abstinent days, higher rates of complete abstinence from cocaine, and a decreased risk of cocaine lapse over time.” Abstinence among participants was verified through urinalysis. “These findings suggest psilocybin shows promise as a novel treatment for cocaine use disorder.” “Whereas pharmacotherapies have been developed for several substance use disorders, medications for stimulant use disorders remain elusive,” the study authors said. “This randomized clinical trial is the first, to our knowledge, to demonstrate that psilocybin coupled with psychotherapy may be safe and efficacious in the treatment of CUD.” The findings from the study “are a potentially important advancement in the treatment of CUD, a condition for which there are no approved pharmacotherapies and limited psychosocial interventions,” they wrote. The study is also notable in that it involved participants from demographics that haven’t historically been adequately represented in psychedelics research; that is, Black and participants of lower socioeconomic status were recruited for the research. “The representation of vulnerable populations in psychedelic clinical trials has been a crucial ongoing concern,” the researchers wrote, adding that a “recent systematic review found that participants in US-based psychedelic trials typically had higher socioeconomic status than the general population.” “The present study demonstrates that psilocybin treatment can be feasibly implemented with Black and socioeconomically disadvantaged individuals vulnerable to the adverse impacts of CUD but understudied in psychedelic research,” the study said. All told, the study concluded that “psilocybin appeared to be safe and efficacious for treating cocaine use disorder among individuals from underrepresented and vulnerable populations,” though additional research “is warranted to replicate and expand these findings.” The research is being published about two months after AMA released a separate study finding that one dose of psilocybin combined with therapy is associated with “significantly increased long-term abstinence” from cigarettes compared to nicotine patches. That indicates the psychedelic “holds potential in the treatment of tobacco use disorder,” the researchers said. As psychedelics policy reform advances in state legislatures across the U.S. and in Congress, Americans have shown growing interest in exploring the therapeutic potential of substances like psilocybin. To that point, a RAND Corporation analysis recently found that nearly 10 million American adults microdosed psychedelic drugs such as psilocybin, LSD or MDMA in 2025. A scientific review published by AMA last year that use of psilocybin has “surged” in the U.S. in recent years amid the decriminalization movement and in light of “promising clinical trial results” on its therapeutic potential. But the paper also pointed out that current federal laws present “a major barrier” to researchers gaining a better understanding of the psychedelic substance’s true impacts. Meanwhile, another study from last year found that psilocybin-assisted psychotherapy “showed significant reductions in alcohol consumption and high smoking cessation rates” and has potential to lessen opioid dependence. In 2024, meanwhile, two other studies—including one with contributions from a top federal drug official—examined psychedelics and alcohol use disorder (AUD). One found that a single dose of psilocybin “was safe and effective in reducing alcohol consumption in AUD patients,” while the other concludes that classic psychedelics like psilocybin and LSD “have demonstrated potential for treating drug addiction, especially AUD.” The National Institutes of Health that year also announced that it would put $2.4 million toward funding studies on the use of psychedelics to treat methamphetamine use disorders—funding that came as federal health officials noted sharp increases in deaths from methamphetamine and other psychostimulants in recent years, with fatal overdoses involving the substances rising nearly fivefold between 2015 and 2022. In 2023, the National Institute on Drug Abuse (NIDA) announced a $1.5 million funding round to further study psychedelics and addiction. Meanwhile, the Trump administration has recently taken steps to explore the therapeutic potential of psychedelics such as ibogaine, which has been touted as a potentially life-saving treatment option for people suffering from serious mental health conditions such as post-traumatic stress disorder (PTSD) and substance use disorder. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Other research has also suggested that psychedelics could unlock promising new pathways to treat addiction. A first-of-its-kind analysis in 2023 offered novel insights into exactly how psychedelic-assisted therapy works for people with alcohol use disorder. In 2024, the National Center for Complementary and Integrative Health (NCCIH), which is part of the National Institutes of Health (NIH), identified the treatment of alcohol use disorder as one of a number of possible benefits of psilocybin, despite the substance remaining a Schedule I controlled substance under U.S. law. The agency highlighted a 2022 study that “suggested that psilocybin may be helpful for alcohol use disorder.” The research found people who were in psilocybin-assisted therapy had fewer heavy-drinking days over 32 weeks than the control group, which NCCIH said “suggests that psilocybin may be helpful for alcohol use disorder.” Image element courtesy of Dominic Milton Trott. The post A Single Dose Of Psilocybin Appears To Safely Treat Cocaine Addiction, New Study Published By American Medical Association Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Bipartisan congressional lawmakers have filed an amendment that would allow military veterans to receive recommendations for medical marijuana through their doctors at the Department of Veterans Affairs (VA). The proposal from Reps. Brian Mast (R-FL), Dave Joyce (R-OH) and Dina Titus (D-NV), if enacted, would prevent VA from enforcing a longstanding directive that has blocked its providers from assisting veterans with registering for state medical cannabis programs. Under current policy, VA doctors can discuss marijuana use with their patients, but they cannot fill out forms to help them actually get legal access to cannabis. As a result, veterans need to seek outside, often expensive, services from separate providers instead of just being able to get assistance from their own doctors at VA. That would change under the new amendment from the co-chairs of the Congressional Cannabis Caucus, which is being offered to the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act. The House Rules Committee is expected to meet next week to decide which submitted amendments can be considered for floor votes. The veterans medical marijuana amendment reads: “SEC. __. None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used to enforce Veterans Health Directive 1315 as it relates to— (1) the policy stating that ‘VHA providers are prohibited from completing forms or registering Veterans for participation in a State-approved marijuana program’; (2) the directive for the ‘Deputy Under Secretary for Health for Operations and Management’ to ensure that ‘medical facility Directors are aware that it is VHA policy for providers to assess Veteran use of marijuana but providers are prohibited from recommending, making referrals to or completing paperwork for Veteran participation in State marijuana programs’; and (3) the directive for the ‘VA Medical Facility Director’ to ensure that ‘VA facility staff are aware of the following’ ‘[t]he prohibition on recommending, making referrals to or completing forms and registering Veterans for participation in State-approved marijuana programs.'” While similar proposals on veterans’ medical marijuana access have been passed by both the House of Representatives and Senate in past years, they have never been enacted into law. Last year, when the House- and Senate-passed language was left out of the final bill sent to President Donald Trump, Mast told Marijuana Moment that the exclusion was “ridiculous.” “It was a great and easy opportunity to do so, and a sensical thing to move forward—and detrimental to veterans to not do so,” he said. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The current amendment comes just weeks after medical marijuana was rescheduled under federal law by the Trump administration, a major policy and political development that advocates hope could boost the chances of the veterans-focused reform being enacted this year. A separate amendment to the military and veterans spending bill from Reps. Lou Correa (D-CA) and Jack Bergman (R-MI), who co-chair the Congressional Psychedelics Advancing Therapies Caucus, seeks to raise awareness about the benefits of psychedelic and other therapies for military veterans. Its description says it “increases and decreases funding for the Medical and Prosthetic Research account at the Department of Veterans Affairs to emphasize the importance of the Department’s research on areas benefiting veterans such as oncology, traumatic brain injury care, psychedelic therapies, and assistive devices.” Meanwhile in Congress, the House Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies approved a bill last week containing provisions that would block federal officials from taking further steps to reschedule cannabis. Separately, the House Appropriations Committee last week approved a separate spending bill and an attached report that expresses concerns about health risks from cannabis-derived products, while also encouraging research into the therapeutic benefits of psychedelics. The full House also recently passed a Farm Bill with provisions aimed at aiding industrial hemp producers—but without any language to delay or alter the federal recriminalization of hemp THC products that’s scheduled to take effect later this year. A new report from the Congressional Research Service details the scope and limitations of the federal marijuana rescheduling move. The post Military Veterans Could Get Medical Marijuana Recommendations Through The VA Under New Congressional Amendment appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“This bill completely put my clients out of business. There were no ways to get rid of the inventory except to destroy it.” By Megan Henry, Ohio Capital Journal A new law banning low-level THC hemp products and changing the state’s marijuana laws hurts Ohio businesses, plaintiffs argued during a preliminary injunction hearing Monday. Happy Harvest and Get Wright Lounge filed a lawsuit in Franklin County Court of Common Pleas after Ohio Senate Bill 56 took effect March 20 after Ohioans for Cannabis Choice failed to get enough signatures to get a referendum on the November ballot for voters to block the law. Franklin County Court of Common Pleas Magistrate Jhay Spottswood-Harrison heard the preliminary injunction hearing. “This bill completely put my clients out of business,” said Scott Pullins, the attorney for the plaintiffs. “There were no ways to get rid of the inventory except to destroy it, and the court attempted and succeeded in fashioning a fair and equity remedy to solve that problem,” he said. “Now, would we like to see it extended statewide to any other retailers in a similar situation.” Franklin County Court of Common Pleas Judge Jeffrey M. Brown issued a 14-day TRO on April 22 allowing Happy Harvest locations and Get Wright Lounge to sell their existing products, but the 10th District Court of Appeals stayed the TRO last week. Happy Harvest has locations in Delaware, Marion and Wood counties. Get Wright Lounge has one location in Columbus. “The TRO restores the status quo that existed for years before March 20, 2026, and in fact, the TRO strengthens what the law was back then by expressly putting in more stringent age restrictions, more restrictions against marketing children, more restrictions as to products that look like hemp,” Pullins said. The state argued Ohio’s law now aligns with new federal restrictions on hemp products that are set to take effect November 12. Congress voted in November to ban products that contain 0.4 milligrams of total THC per container when they voted to reopen the government. The only way to sell marijuana in Ohio starting November 12 is by getting a license from the Ohio Division of Cannabis Control, said Ann Yackshaw, assistant section chief in the Ohio Attorney General’s office. “The only way for plaintiffs or anyone else to get that license is to let Senate Bill 56 continue in effect so that the Division [of Cannabis Control] can continue to regulate and continue to build out the regulatory framework to bring these people into cannabis regulation in the state of Ohio,” Yackshaw said. “Putting Senate Bill 56 on hold would put that rule-making process on hold, and then no one would be able to get into the cannabis program in the state of Ohio,” she said. Previously, the 2018 Farm Bill said hemp can be grown legally if it contains less than 0.3 percent THC. But the 2018 Farm Bill created challenges from a definition standpoint and a series of loopholes, said Andrew Makoski, chief legal counsel for the Ohio Division of Cannabis Control. “Hemp products exploded, not just in Ohio, but all across the country, where people were using the hemp definition to sell these intoxicating products that had the technical definition of hemp,” he said. “With any kind of unregulated marketplace, you don’t know what you’re actually getting. What you found was a large spike in accidental ingestions,” he said. Stopping S.B. 56 would take Ohio back to an unregulated market where “any child or anybody could walk into a store buy whatever they want,” Makoski said. Ohio Senate Bill 56 The bill had to go to conference committee in the Ohio legislature after it passed the Ohio House, but the Ohio Senate voted not to concur with changes made to the bill at the end of October. “The General Assembly enacted a sweeping criminal statute through a midnight conference report that neither chamber ever read three times in its final form and that consolidated four separate bills…into a single omnibus vehicle,” Pullins said. Under the new law, THC levels in adult-use marijuana extracts will be reduced from a maximum of 90 percent down to a maximum of 70 percent, cap THC levels in adult-use flower to 35 percent and prohibit smoking in most public places. The new law prohibits possessing marijuana in anything outside of its original packaging, criminalizes bringing legal marijuana from another state back to Ohio, and requires drivers to store marijuana in the trunk of their car while driving. “Customers who wish to get lower prices and go to Michigan and other states have now been declared to be felons if they buy the product and bring it back here,” Pullins said. The new law funnels unregulated THC through the Ohio Division Cannabis Control, Yackshaw said. “That is the regulation that plaintiffs say that they were looking for, but they don’t want it because they don’t want to have to go through the stringent procedures that the Division of Cannabis Control lays out,” she said. Mark Fashian was the president of hemp product wholesaler Midwest Analytical Solutions in Delaware, Ohio, but he is now out of business because of the new law. “After March 20, my sales have died,” Fashian said. “[Senate Bill 56] basically made everything that I do illegal… I have five employees, and right now they’re finding other jobs.” Happy Harvest was one of his best customers and they have more than $200,000 of stranded inventory, Fashian said. “Every day [Ohio Senate Bill 56] is enforced, it destroys lawful Ohio businesses, businesses operating a good faith reliance on the 2018 federal Farm Bill,” Pullins said. A Sandusky County judge last month issued a TRO on the hemp portion of the new law which allows the sale of intoxicating hemp products to continue in Fremont. This story was first published by Ohio Capital Journal. The post Ohio Court Hears Arguments On Blocking New Hemp Product Restrictions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with extra information? It is extremely helpful for me. エアコン掃除 大阪

Positive site, where did u come up with the information on this posting?I have read a few of the articles on your website now, and I really like your style. Thanks a million and please keep up the effective work. slot

“I still think it doesn’t make a whole lot of sense to have a cap. But if people felt strongly about it, we agreed to it.” By Emilia Otte, CT Mirror The House and Senate voted Tuesday to reinstate a cap on the amount of THC content in cannabis flower after an attempt to remove that limitation a few weeks ago was met with pushback from lawmakers. Prior to this year’s legislative session, Connecticut law capped the THC content in cannabis flower at 35 percent. A bill passed in April removed that cap. At the time, Rep. Roland Lemar, D-New Haven, said cannabis plants have their own natural limits on THC concentration and that “watering down” the cannabis could actually be more dangerous because it would involve substances that have not been tested or regulated. But Rep. David Rutigliano, R-Trumbull, argued that higher concentrations of THC would make it easier for people to become addicted. He noted that public health professionals who appeared at a public hearing on the bill also brought concerns about THC levels. House Majority Leader Jason Rojas told the Connecticut Mirror Wednesday that the caps were replaced after members of the Senate expressed concern. “I still think it doesn’t make a whole lot of sense to have a cap. But if people felt strongly about it, we agreed to it,” Rojas said. Lemar said that while the legislature overall appeared willing to loosen some regulations on the cannabis industry that created challenges for business owners, removing the THC cap on flower was a sticking point. “ I think it puts [businesses] at a competitive disadvantage vis-à-vis some other states. But at the end of the day, the regulators and the legislators who were tasked with making the responsible choice didn’t feel comfortable in that space moving to an uncapped system,” he said. Rojas said he didn’t believe restoring the cap on flower would cause problems for the industry, since the difference between natural THC limits in flower and the caps in the bill were minimal. Sen. James Maroney, D-West Haven, said there were similar concerns in the Senate about the removal of the THC cap for flower. The original bill that removed the caps passed 18-17 with a promise that an imminent bill would restore those caps. During a Senate debate on the bill removing the caps, several senators—Republican and Democrat—expressed concern about how increased THC potency could affect public health, particularly for children. “This is not fun and games. This is life and death. This is life changing, family changing, family destroying when we eliminate these caps,” said Sen. Jason Perillo, R-Shelton. Sen. Christine Cohen, D-Guilford, also expressed “strong reservations” with the THC potency levels and their impact on mental health. Aside from the THC flower cap, the original bill eliminated caps on THC concentrates and increased the amount of THC allowed in infused drinks from 3 mg to 5 mg. Drinks sold in dispensaries or retailers may now have up to 10 mg of THC. The bill also expanded the cannabis marketplace to include topicals, tablets and capsules and allows patients who come from out-of-state to purchase cannabis for medical reasons. Those changes are still in place. Sen. Paul Cicarella, R-North Haven, said he hoped the legislature next year could consider setting limits to THC in other forms of cannabis, like edibles or tinctures. “Marijuana is a concern. Increasing these levels is a concern of multiple people around this circle, regardless of party,” he said. This article first appeared on CT Mirror and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License. Photo courtesy of Brian Shamblen. The post Connecticut Lawmakers Pass Bill To Reinstate THC Limits For Marijuana Flower appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Indiana’s Republican governor recently said that his state is “more likely” to legalize marijuana now that the Trump administration is moving to federally reschedule cannabis—but a GOP senator is pressing Gov. Mike Braun (R) to maintain criminalization. “Recently, you suggested that Indiana will have to address marijuana legalization. I urge you to prioritize public safety and the well-being of Hoosiers—especially those under the age of 18—and maintain the state’s prohibitions on marijuana use,” Sen. Jim Banks (R-IN) wrote in a letter to the governor last week. “Marijuana is not a harmless drug.” Banks listed a number of concerns, including about cannabis use disorder, impaired driving and criminal activity. “Even a single use affects a person’s brain and ability to make decisions. The risks are elevated in children, whose brains are not fully developed,” he wrote. “Making marijuana legal does not make it safe, and it does not reduce usage.” “Even in states that limit recreational use, addicts are accessing medical marijuana cards—and medical use itself can lead to use disorders. Experiments in legalization have consequences for communities as well as individuals,” the senator said. “This is to say nothing of the fact that legalization empowers foreign drug cartels, a concern I have previously raised with my colleagues at the national level.” “Indiana needs to enforce its laws protecting Hoosiers from the dangers of drug use. I hear regularly from constituents about this issue, and they want more regulation, not less,” Banks wrote in the letter, which was first reported by Daily Wire. “They tell me about how their children’s lives were ruined by addiction; how they treat the consequences of cannabis disorder in hospitals every day; and how schools are struggling to stop students from smuggling marijuana onto campus using vape pens. We owe it to them, and to all the residents of our great state, to keep Indiana safe, beautiful, and drug-free.” Under an order signed last month by U.S. Acting Attorney General Blanche, marijuana products regulated by a state medical cannabis license immediately moved to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). “I think the fact that the feds made that move, that makes it more likely” the state will act to reform its cannabis laws, Braun said last week. “You’re going to need to ask the legislators and the leaders in those two chambers to see what they’re thinking, because I’m clear in terms of where I’m at,” he continued. “You’ve got to take what’s evolved over time. [If you] stick your head in the sand, you’re generally going to make the wrong decision.” Meanwhile, at Braun’s direction, state officials have been holding a series of meetings with medical marijuana advocates. Last month, the governor said the “crescendo will rise” in the call to legalize marijuana, with regional dynamics and even law enforcement buy-in favoring reform down the line. But for now, he said GOP legislative leadership in the state is “not interested in doing anything soon,” even if “over half of Hoosiers probably smoke it illegally.” Braun said at the time that he thinks lawmakers should take “an additional look at” medical cannabis and that, while he’s personally “agnostic” on legalization, the reality is that Indiana is “surrounded now by four states” that allow either medical or adult-use cannabis. “Over half of Hoosiers probably smoke it illegally,” he said, noting that neighboring Kentucky permits patients to access medical cannabis, while Illinois, Michigan and Ohio have recreational marijuana laws on the books. “I’m going to listen to law enforcement. Even they have changed their opinion in terms of legalizing it and regulating it,” Braun said, adding that he’d compare cannabis to gambling. The state was late in the game to adopt laws allowing adults to gamble, he said, but now it ranks in the top three states nationwide in terms of revenue per capita from the vice. “Some people aren’t going to want it, just out of principle. A lot of our state police and sheriffs are tolerating people going across the border [to buy cannabis]. It’ll be an increasing issue that, so far, our state legislature has kind of dug in against it,” he said. “I’ve been more agnostic about it. I can see points of view, and I’ve seen law enforcement move on it somewhat.” “So that would give you the best description of where the dynamic is in our state,” the governor told WOWO. “I think the leader of the Senate especially, and the Speaker of the House, are pretty—and they control the legislative agenda—not interested in doing anything soon. But I think the crescendo will rise, and that describes in a snapshot where we’re at.” Braun similarly talked about the issue in another recent interview, saying the state is “probably going to have to address” the issue and likening cannabis reform to sports betting. Lawmakers in the state had already signaled that marijuana legalization isn’t in the cards in the 2026 session, meaning another year where Indiana will be an outlier as one of the few remaining states without effective medical or adult-use cannabis laws. The governor separately said in January that he’s “amenable” to the idea of legalizing medical cannabis in the state. Instead, Indiana legislators this session have been focused on efforts to ban hemp THC products—though it seems that fight is over for 2026 after a last-minute push failed late last month. Braun has previously said that federal marijuana rescheduling could add “a little bit of fire” to the local push for cannabis legalization in his state. Among Indiana residents, a survey released in January found that nearly three in five back legalizing cannabis for medical and recreational use. Specifically, the annual Hoosier Survey from the Bowen Center at Ball State University (BSU) found that 59 percent of residents are in favor of legalizing cannabis for both medical and recreational purposes. An additional 25 percent back only allowing patients to access medical marijuana, raising the total support for that reform to 84 percent. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Braun, for his part, previously said that “it’s probably time” to allow access to therapeutic cannabis among patients in the state. Those comments came alongside a separate poll indicating that nearly 9 in 10 Indiana adults (87 percent) support marijuana legalization. Top Republicans in the legislature, however, have openly opposed marijuana reform. “It’s no secret that I am not for this,” Senate President Pro Tem Rodric Bray (R) said in late 2024. “I don’t have people coming to me with really compelling medical cases as to why it’s so beneficial. And any state that I’ve seen pass medical marijuana is essentially passing recreational marijuana.” House Speaker Todd Huston (R) doubted any medical benefits associated with marijuana, calling the substance “a deterrent to mental health.” He and others suggested that lawmakers supportive of the reform merely want to boost state revenue. Read the senator’s full marijuana letter below: The post GOP Senator Urges Indiana Governor Not To Legalize Marijuana Despite Federal Rescheduling appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with extra information? It is extremely helpful for me. toto

You know your projects stand out of the herd. There is something special about them. It seems to me all of them are really brilliant! bandar togel online Thanks for sharing us. flatshare Athens expats You know your projects stand out of the herd. There is something special about them. It seems to me all of them are really brilliant! bandar togel online Thanks for sharing us. ดูมวย You know your projects stand out of the herd. There is something special about them. It seems to me all of them are really brilliant! Asiapowerball Thanks for sharing us. แทงวอลเลย์บอล ไม่ผ่านเอเย่นต์

I have read your article, it is very informative and helpful for me.I admire the valuable information you offer in your articles. Thanks for posting it.. togel online Great survey, I'm sure you're getting a great response. cost of living Greece 2026 I have read your article, it is very informative and helpful for me.I admire the valuable information you offer in your articles. Thanks for posting it.. situs toto macau Great survey, I'm sure you're getting a great response. ดูมวย I have read your article, it is very informative and helpful for me.I admire the valuable information you offer in your articles. Thanks for posting it.. Asiapowerball Great survey, I'm sure you're getting a great response. แทงวอลเลย์บอล ไม่ผ่านเอเย่นต์

ID medical marijuana ballot sigs; AZ legalization rollback stalls; FL gov candidates on cannabis; Target expands hemp THC drink sales; LA penalties Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Congressional Research Service published a report detailing the scope and limitations of the Trump administration’s marijuana rescheduling move for consumers and businesses, saying it “does not immediately bring the state-legal marijuana industry into compliance with federal law” but “appears to authorize end users to possess marijuana for medical use without a [Controlled Substances Act]-compliant prescription.” “With respect to the manufacture, distribution, and possession of recreational marijuana, even if marijuana were completely moved to Schedule III, such activities would remain illegal under federal law and potentially subject to federal prosecution regardless of their status under state law.” An Idaho medical cannabis campaign announced it turned in more than 150,000 signatures to qualify a legalization initiative for the November ballot—a raw total that is more than double the amount of verified petitions needed, though there are also regional requirements. An Arizona anti-marijuana campaign is no longer seeking to put an initiative on the November ballot to roll back the state’s legalization law after its leader said he has “adjusted my viewpoints on the threat to kids” posed by the legal cannabis industry. The Louisiana Senate Judiciary B Committee approved a House-passed bill that threatens to send people to jail for up to one year if they smoke marijuana within 2,000 feet of a school property—including college campuses. Target is expanding its sales of hemp-derived THC drinks into three of the U.S.’s most populous states—a move that comes as a law signed by President Donald Trump is set to federally recriminalize the products later this year. Florida Republican gubernatorial candidates are united in opposing marijuana legalization, while former Rep. David Jolly (D-FL) said, “I think the governor’s role is to represent the majority of the state, and the majority of the state asked for it.” Rep. Byron Donalds (R-FL) said, “I do not support recreational marijuana. I think the current regulatory system around medicinal use is fine.” / FEDERAL The Food and Drug Administration announced its first authorization of fruit-flavored electronic cigarettes. The Department of Health and Human Services promoted a video of a military veteran who used psychedelics to treat PTSD. Sen. Rand Paul (R-KY) tweeted, “A federal hemp ban would devastate American farmers and small businesses while pushing products into unregulated markets. My Hemp Safety Enforcement Act takes a smarter approach: States choose their own hemp regulations Synthetic cannabinoids banned across the board Consumer protections without an outright prohibition No more Washington dictating policy to the states No more one-size-fits-all federal overreach That’s how you protect people and an industry at the same time.” Nebraska independent Senate candidate Dan Osborn tweeted, “The Trump administration reclassified marijuana from a Schedule I drug to a Schedule III drug. That’s a win for Nebraska farmers and a win for patients and caregivers who can finally access the medicine they need.” / STATES The Virginia Senate president’s offices and businesses, including a cannabis store, were raided by federal officials. Pennsylvania representatives offered contrasting perspectives on marijuana legalization. A Texas senator cited recent hemp product restriction developments, tweeting, “Texas was ahead of the curve on THC.” A Florida appeals court dismissed the state’s appeal of a lower court ruling that suppressed marijuana evidence found during a traffic stop. Colorado regulators issued a health and safety advisory about marijuana products that exceed acceptable limits for total yeast and mold. Montana regulators filed proposed changes to rules on marijuana product recalls. Maryland regulators published guidance on federal marijuana rescheduling. California regulators sent updates about various cannabis issues. Oregon regulators are holding listening sessions about the psilocybin services program this week. The Rhode Island Cannabis Control Commission will meet on Friday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Sacramento, California City Council is considering a proposal to use cannabis revenue to fund a basic income for former foster youth. / INTERNATIONAL Israel’s health minister is pausing a proposal to restrict medical cannabis, including by disallowing smoking of it. / SCIENCE & HEALTH A review concluded that “cannabinoids may provide analgesic benefits for patients with fibromyalgia.” A review concluded that “analysis of Phase II and Phase III clinical trial data shows that MDMA-assisted psychotherapy produces [post-traumatic stress disorder] remission rates of about 46% to 67%, significantly higher than the 20% to 30% remission rates of currently approved pharmacologic treatments.” / ADVOCACY, OPINION & ANALYSIS The Marijuana Policy Project published a voter guide for Pennsylvania’s primary elections. / BUSINESS ACE Venture, LLC completed its 51 percent acquisition of Vireo Health of New York. Green Thumb Industries Inc. reported quarterly net revenue of $300.2 million. Innovative Industrial Properties, Inc. reported quarterly revenue of $69 million. RYTHM, Inc. reported quarterly revenue of $13.3 million. / CULTURE Michael Jackson’s former publicist said the singer used marijuana as an “escape from life.” Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Congressional report on what cannabis rescheduling does—and doesn’t do (Newsletter: May 7, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Please share more like that. togel I have read all the comments and suggestions posted by the visitors for this article are very fine,We will wait for your next article so only.Thanks! rent apartment Athens Greece Please share more like that. alexistogel link I have read all the comments and suggestions posted by the visitors for this article are very fine,We will wait for your next article so only.Thanks! แทงมวย Please share more like that. Asiapowerball I have read all the comments and suggestions posted by the visitors for this article are very fine,We will wait for your next article so only.Thanks! แทงวอลเลย์บอล

Snow Rider does not require high system specifications or complex installation, and can be played instantly on a wide range of devices. The game offers quick, entertaining fun that fits perfectly with the pace of modern life.

We provide exclusive companionship solutions for clients who value privacy and quality service. Every detail is handled carefully to create a seamless experience. When selecting Escorts Service in Janakpuri, you can expect professionalism, reliability, and an atmosphere focused entirely on your comfort.

Playing Friday Night Funkin also helps me reduce stress. After a busy day, the fast-paced rhythm and exciting gameplay help me relax and improve my mood.

“I do not support recreational marijuana. I think the current regulatory system around medicinal use is fine.” By Mitch Perry, Florida Phoenix The issue of whether Florida should legalize recreational cannabis went away as a significant campaign issue earlier this year after Smart & Safe Florida, the organization behind an initiative to put it back before voters this November, fell short of the nearly 880,000 verified petition signatures required to qualify for the statewide ballot. That failure came a year-and-a-half after nearly 56 percent of Floridians voted to legalize adult use of recreational marijuana on the November 2024 ballot, a clear majority but short of the 60 percent required for passage. While it’s not something voters will decide this year, Floridians might want to know where their candidates for statewide office stand. Speaking during a “Business Women for Byron” campaign event Tuesday at the Getaway, a waterfront restaurant and Tiki bar in St. Petersburg, the first question asked by an audience member to GOP gubernatorial candidate Byron Donalds was his position on the topic. “I do not support recreational marijuana,” Donalds replied. “I think the current regulatory system around medicinal use is fine.” Donalds has previously acknowledged that he was arrested for possessing “a dime bag of marijuana” as a teenager, and admitted to CBS Miami recently that he actually had sold small amounts of cannabis as a youth. He now says that he doesn’t support expanding the legal use of weed beyond the 924,820 Floridians listed as qualified medical marijuana patients, according to the state Office of Medical Marijuana Use. Acceptance On Medical, But Never For Recreational The other Republicans running for governor share Donalds’s sentiments. “I oppose recreational marijuana in Florida,” investment firm CEO James Fishback told the Phoenix in a text message. “I have seen what it has done to cities that have already tried it, from New York to Chicago to Washington D.C. The foul stench of pot in public parks and outside our schools can never come to Florida.” However, Fishback says he will always protect the right of those “with a legitimate medical purpose, including our U.S. military veterans.” “No one should be denied herbal medicine and pushed toward addictive big pharma prescriptions for pain,” he said. “As Governor, I will protect medical marijuana. But I won’t tolerate hoodlums smoking pot in a public park, just as we already don’t tolerate them drinking in one.” “I’ve been clear from day one. I am completely against legalizing marijuana,” Lt. Gov Jay Collins said in a video posted on social media on April 26. “We’ve seen the impact in other states, and that’s not where Florida is headed. I stand with Governor DeSantis on this. No compromises, and no money from the marijuana industry. That can’t be said for all of my opponents.” “I’m against full blown recreational marijuana,” former House Speaker Paul Renner said Wednesday during a roundtable discussion of high energy prices in Hillsborough County. “We have medical. It was put in the Constitution [in 2016]. If people want to get it, they can get it. And we opened that up to the extent where it needs to be, but I’m opposed to recreational. Period. If it came back on the ballot, I would campaign against it like Gov. DeSantis did.” DeSantis announced in June 2024 that he would use a political action committee to fight the constitutional amendment on recreational marijuana, saying he could not believe that the Florida Supreme Court allowed the language of the measure to qualify for that November’s ballot. He later used tens of millions of taxpayer dollars to campaign against both that proposal and another measure that would have enshrined abortion rights in Florida, according to a report by the Tampa Bay Times. Where Are The Democrats? The Phoenix reached out to the two major Democrats running for governor this year: former GOP U.S. Rep. David Jolly and Orange County Mayor Jerry Demings. “I think the governor’s role is to represent the majority of the state, and the majority of the state asked for it, and I think that we should do it,” Jolly told the Phoenix in a phone call Tuesday. The Pinellas County Democrat says he actually voted against Amendment 3 in 2024, the one calling for legalizing adult use of recreational marijuana. But since he announced his candidacy last year, Jolly has emphasized that he would work to implement all recent constitutional amendments that have been passed by a majority of Floridians but failed to get the high 60 percent margin required for passage. “Recreational marijuana got more than 50 percent of the vote in the constitutional amendment process and I pledged to support the enactment and introduce legislatively any amendment that got more than 50 percent of the vote. That includes open primaries, recreational marijuana, and Amendment 4 on reproductive freedom,” he said. The only major gubernatorial candidate whose stance the Phoenix was unable to clarify was Demings. While serving as the police chief for the city of Orlando in the 2010s, Demings opposed the constitutional amendments that would have legalized medical marijuana in both 2014 and 2016. The Phoenix reached out by phone and by email to the Demings campaign for two days this week but did not receive a response. Calls to the phone number listed on the most recent press release from the Demings campaign were answered by a recording saying that the person with the number had not set up a voice mail system. President Trump Endorsed Amendment 3 One prominent Florida Republican who supported Amendment 3 in 2024 was President Donald Trump. “As I have previously stated, I believe it is time to end needless arrests and incarcerations of adults for small amounts of marijuana for personal use. We must also implement smart regulations, while providing access for adults, to safe, tested product,” Trump posted on Truth Social in September 2024. “As a Floridian, I will be voting YES on Amendment 3 this November.” In that post, the president promised that if elected back to the White House he would work towards changing marijuana from a Schedule I drug under the Controlled Substances Act to a Schedule III drug—which he did in December in an executive order. The U.S. Department of Justice announced last month that it would immediately move FDA-approved marijuana products, along with items regulated by a state medical marijuana license, to Schedule III. That puts medical cannabis into the group of regulated drugs with recognized medical uses, such as Tylenol, rather than Schedule I drugs, like heroin and LSD, which are considered to have no medical use and have a high potential for abuse. This story was first published by Florida Phoenix. Photo courtesy of Philip Steffan. The post Florida Republican Governor Candidates Are United In Opposing Marijuana Legalization appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

An Idaho medical marijuana campaign has announced that it turned in more than 150,000 signatures for a proposed legalization initiative it wants to qualify for the state’s November ballot. The Natural Medicine Alliance of Idaho (NMAI) announced on Wednesday that it submitted the petitions ahead of last week’s deadline. County clerks across the state now have until June 30 to verify the signatures and report to the secretary of state’s office. Amanda Watson, a spokesperson for the group, said that the petitions come from all 44 of the state’s counties and are the result of a “rigorous signature gathering effort that stretched to every corner of Idaho.” “During the work our teams did on the ground to reach Idahoans and obtain the necessary signatures (and well beyond), we were moved and inspired by the many individuals who expressed support, shared their stories and reiterated their appreciation for the democratic process that allows for their voice to be heard through a citizen-led effort,” she said. “This milestone belongs to the tens of thousands of Idahoans who signed,” Watson said. “Together, we have moved the Idaho Medical Cannabis Act one step closer to the ballot and one step closer to a decision made by the people of Idaho themselves. Now we await the count, and the chance to bring this issue before voters in November.” At this stage, it’s unclear how many signatures the campaign has collected to far are valid and whether activists have met a separate requirement for regional distribution of petitions. To be certified for the ballot, the team needs to submit signatures from at least 6 percent of registered voters as of the state’s last general election, which currently amounts to 70,725. They also need to meet that 6 percent threshold in at least 18 of the state’s 35 legislative districts. While NMAI has pursued ballot access, Idaho lawmakers have pushed back. Both the Senate and House of Representatives passed a resolution this session urging voters to “reject” the medical marijuana petition. The measure, sponsored by the Senate State Affairs Committee, claims that cannabis legalization in other states has led to a host of harms, including “increased cartel activity, development of black market marijuana production, human trafficking, and increased crime rates” as well as “increased rates of serious health issues,” environmental harms and “safety concerns on job sites.” It argues that the marijuana initiative would not only increase costs to the state but that its list of approved medical conditions is “so broad that almost anyone could qualify.” “The Idaho Medical Cannabis Act lacks safeguards to such an extent that it would effectively legalize widespread recreational use of marijuana,” the resolution claims. “The legalization of marijuana would have devastating impacts on Idaho children and their families… The Legislature urges the citizens of Idaho to reject any effort to bring the Idaho Medical Cannabis Act to the ballot.” A statement of purpose filed with the legislation says it “addresses the devastating impact that legalizing marijuana has had on other states” and “identifies the significant problems” with the ballot initiative. Contrary to the claims made about marijuana reform in the legislative resolution, advocates often point to data showing that legalizing and regulating cannabis diminishes the size of the illegal market and has not led to increases in youth use. Meanwhile, NMAI recently released an analysis showing that Idaho could see more than $100 million worth of medical marijuana sold on an annual basis and up to $28 million in new yearly revenue for state coffers if voters approve the legalization initiative. The Idaho Medical Cannabis Act, which NMAI unveiled last October, would provide patients with qualifying conditions access to marijuana from a limited number of dispensaries and provide a regulatory framework for the market. Here are the main provisions of the Idaho Medical Cannabis Act: Health practitioners would be able to recommend medical cannabis to patients with conditions that include, but are not limited to, cancer, anxiety and acute pain. Medical marijuana patients or their designated caregiver could purchase up to 113 grams of smokeable cannabis, or 20 grams of THC extract for vaping, per month. The state would be start by issuing three vertically integrated cannabis business licenses, after which point it could license up to six total. Marijuana would be reclassified under state law as a Schedule II, rather than Schedule I, controlled substance. State and local law enforcement would be barred from assisting in federal drug enforcement activities related to the state-legal cannabis program. There would be anti-discrimination protections for those who use or sell marijuana in compliance from state law, preventing adverse actions by employers, landlords and educational institutions. It does not appear that there would be any equity-centered reforms, nor would the initiative provide for a home grow option. “We believe Idahoans deserve access to legal, compassionate, natural care right here at home,” NMAI’s website says. “Our mission is to give patients a legal pathway to natural medicine that can ease suffering and restore dignity without the fear of addiction.” “The Idaho Medical Cannabis Act is our first step forward. It creates a safe, tightly regulated medical program that allows qualified Idahoans to seek medical cannabis treatment with a valid diagnosis from a healthcare provider,” it says. “It supports Idaho agriculture, generates tax revenue to reinvest locally, and ensures that patients can find natural relief.” The campaign in February also released the results of a statewide poll showing that 83 percent of likely voters back medical cannabis legalization, including 74 percent of Republicans, 95 percent of Democrats and 92 percent of independents. Asked how they would vote if the current medical cannabis legalization does appear on the November ballot, 76 percent of respondents said “yes.” Of that cohort, 50 percent said they would “definitively” vote yes, and just 21 percent said they’d vote “no.” After the medical cannabis initiative was unveiled last year, a separate campaign that launched in 2024, Kind Idaho, told supporters that it would be suspending its own signature gathering for a ballot initiative to legalize the personal possession and cultivation of marijuana by adults. Kind Idaho previously introduced medical marijuana ballot measures intended to go before voters in both the 2022 and 2024 elections, but the efforts proved unsuccessful. Meanwhile, voters this year will see a different kind of proposal on the ballot: A constitutional amendment that the legislature approved to make it so only lawmakers could legalize marijuana or other controlled substances. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Legislators separately held a hearing last year to discuss a bill to enact medical cannabis legalization legislatively, but there hasn’t been meaningful action on the issue in the months since. Separately, a bill from Rep. Bruce Skaug (R) last year would have set a $420 mandatory minimum fine for cannabis possession, removing judges’ discretion to apply lower penalties. Skaug said the bill, which ultimately stalled in committee, would send the message that Idaho is tough on marijuana. House lawmakers also passed a bill to ban marijuana advertisements, though the Senate later defeated the measure. The post Idaho Medical Marijuana Campaign Turns In 150,000 Signatures For Legalization Ballot Measure appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Louisiana Senate committee has approved a House-passed bill that threatens to send people to jail for up to one year if they smoke marijuana within 2,000 feet of a school property—including a college campus. The legislation from Rep. Gabe Firment (R) cleared the Senate Judiciary B Committee in a 3-2 vote on Tuesday, weeks after being passed by the House of Representatives. HB 568, which could receive a Senate floor vote soon, applies to people who violate drug laws “while smoking, vaping, or otherwise abusing such controlled dangerous substance while on any property used for school purposes by any school, within two thousand feet of any such property, or while on a school bus.” Firment told senators that his bill “strengthens enforcement of Louisiana drug-free school zone laws by creating a clear behavior-based offense, so that when someone is openly smoking or vaping illegal drug in the school zone, law enforcement can act and prosecutors can prove the case.” “For marijuana, the bill establishes a clear and consistent penalty—up to a year in jail and $1,000 fine, ensuring that violations in school zones result in real, enforceable consequences,” he said. Kevin Caldwell, Southeast legislative manager for the pro-legalization Marijuana Policy Project (MPP), testified that “Louisiana already has serious penalties for drug offenses.” “This bill would add a mandatory minimum jail sentence for public consumption—not distribution, not intent to sell—simply for being within 2,000 feet of the school,” he said. “This radius covers an enormous portion of most neighborhoods in our cities and towns.” “This is not justice. This is geography used as a trap,” he said, adding that research has shown that “mandatory minimum sentences do not reduce drug use or drug trafficking.” “What they do accomplish is well documented. They strip judges of discretion, they fill jails at taxpayers expense and they fall disproportionately on communities of Black and brown Louisianans who live in denser urban neighborhoods where school zone radius covers virtually every street corner. Louisiana already incarcerates more people per capita than almost any jurisdiction on Earth. This bill would make that worse without making one single child safer.” Facing questions from Democratic senators, Firment defended his bill, arguing that “common sense tells us that the stiffer the penalty, the less inclined people are to participate in that behavior.” Sen. Royce Duplessis (D) said that “while I do believe your intent is to deter, I believe that there’s mounds of data…that will suggest that this type of bill actually does not deter and that it does not lead to the outcome that you might be seeking, no matter how good your intentions might be.” A representative of Gov. Jeff Landry’s (R) office appeared alongside Firment at the hearing in support of the legislation. In 2021, then-Gov. John Bel Edwards (D) signed a bill decriminalizing marijuana by removing the threat of jail time for possessing up to 14 grams. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the Louisiana Senate also recently passed a bill to let patients with terminal and irreversible conditions use medical marijuana in hospitals. The Senate separately approved legislation to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin and ibogaine. Another lawmaker also recently introduced a bill to create an adult-use marijuana legalization pilot program in the state to determine whether the reform should eventually be expanded and permanently codified. Rep. Candace Newell (D)—who has long championed legislation to end cannabis criminalization and filed a similar legal marijuana pilot program measure last session—is sponsoring what’s titled the “Adult-Use Cannabis Pilot Program Regulation and Enforcement Act.” Getting the bill across the finish line could prove complicated in the conservative legislature, however. Newell’s earlier version of the pilot program legislation didn’t advance to enactment last year, and lawmakers that session also rejected other marijuana reform proposals such as one that would have established a tax system to prepare the eventual legalization of adult-use cannabis. The post Louisiana Bill To Jail People For Smoking Marijuana Near College Campuses Advances In Senate appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Major retailer Target is deepening its involvement in the hemp-derived THC beverage market by launching sales in three more states—significantly expanding beyond a pilot program it rolled out in Minnesota last year—even as a federal law is set to ban the products later this year. Last year, the company began a pilot program involving sales of cannabis drinks at 10 select stores in Minnesota. It later applied with state officials for licenses to sell THC beverages at all 72 of its stores in the state, where the company is headquartered. Now, according to BevNET, Target is expanding cannabis beverage sales to more than 300 stores in Illinois, Florida and Texas. That includes every store in the latter two states and select stores in Illinois, due to the fact that some municipalities in the state have restricted hemp product sales. “At Target, we’re always exploring new ways to meet our guests’ evolving preferences, grounded in our merchandising authority and focus on thoughtfully curating a relevant assortment,” a spokesperson told the beverage industry trade publication. The outlet also reported that while the company’s initial launch in Minnesota only included cannabis drinks with a maximum of 5 milligrams of THC, it is now selling beverages with up to double that potency. Target’s expansion of hemp THC beverage sales into the second, third and sixth most populous U.S. states comes months after Congress passed and President Donald Trump signed legislation that will recriminalize hemp-derived products containing more than 0.4 milligrams of THC per container. Bipartisan lawmakers in the U.S. Senate and House of Representatives have pushed for a delay in the scheduled ban, which is set to take effect in November, but those efforts have not gained traction with congressional leadership. “Sources report that Target is believed to be hedging against this potential ban by planning to mark down its intoxicating hemp inventory in October if there is no regulatory solution in place at that point,” BevNET said. THC drink brands that were included in Target’s initial launch in Minnesota included Birdie, Cann, Find Wunder, Gigli, Hi Seltzer, Indeed, Señorita, Stigma, Surly, Trail Magic, Wyld and Wynk. A poll from the cannabis telehealth platform NuggMD last year found that marijuana consumers were encouraged by Target’s decision to start selling THC beverages—with a majority saying the marketing move makes them more likely to shop at the retail giant’s stores. Respondents were asked: “Does knowing this make you more likely to shop at Target in the future?” A total of 50.5 percent said they would be more likely—though that notably includes 34.4 percent who said they’d only be more inclined to patronize Target if their local store carried the THC beverages. Another 16.1 percent said “yes” because they “want to support the retailer more now regardless of which locations sell the products.” About half of respondents (49.5 percent) said Target’s embrace of a THC drink pilot program wouldn’t affect where they shop. The mainstreaming of cannabis beverages comes as recent poll shows that a majority of Americans believe marijuana represents a “healthier option” than alcohol—and that most also expect cannabis to be legal in all 50 states within the next five years. Another survey found that four in five adults who drink cannabis-infused beverages say they’ve reduced their alcohol intake—and more than a fifth have quit drinking alcohol altogether. Wine & Spirits Wholesalers of America this week called out Congress for failing to address the pending federal recriminalization of hemp THC drinks in the Farm Bill that was recently passed the House of Representatives. Target isn’t alone in joining the cannabis train as state laws continue to evolve. Home Depot, one of the largest employers in the United States, last year shifted its employee drug testing policies to remove cannabis from screening panels entirely and stop pre-employment drug testing of most of its workers, according to a document obtained by Marijuana Moment. In 2022, Amazon, the second largest private employer in the U.S., also backed a Republican-led bill to federally legalize, tax and regulate marijuana. It previously expressed support for a separate, Democratic-led legalization bill. Amazon has also worked to adapt to changing marijuana policies internally as it’s backed congressional reform, enacting an employment policy change in 2021 to end drug testing for cannabis for most workers, for example. Meanwhile, Veterans of Foreign Wars (VFW) of the United States recently entered a first-of-its-kind partnership with a hemp THC beverage company, with a licensing branding deal that will support a variety of veterans services and promote cannabis drinks as a potential alcohol alternative with the drinks being available at VFW posts across the country. Separately, while Target is apparently moving into the THC drink space, the airline Virgin Atlantic denied satirical and false claims earlier this year from a cannabis beverage company about a deal to sell its THC-infused beverages on flights. The post Target Is Launching Hemp THC Drink Sales In Three Of The U.S.’s Most Populous States appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Delhi escorts and call girls represent a blend of beauty, elegance, and charm. If you're new to the city and find yourself captivated by the sophistication and allure of Delhi's women, it’s natural to be drawn to them. For an unforgettable experience, consider hiring one of our elite call girls in Delhi for an exceptional night of fun and companionship. Our selection includes high-profile actresses, models, air hostesses, and even adult performers, all dedicated to making your time with them both thrilling and satisfying. These VIP Escorts in Delhi are not only breathtakingly attractive but also intelligent, offering engaging conversations and mesmerizing personalities that will leave you enthralled. Their impeccable grooming, stylish attire, and polished demeanor set them apart from the ordinary escort services available. If you’re ready to meet someone extraordinary and enjoy an experience unlike any other, don't hesitate to book one of our stunning companions today. Delhi Escorts !! Become An Escort !! Cheap Escorts !! Russian Escorts !! Airhostess Escorts !! Housewife Escorts !! Vip Model Escorts !! Celebrity Escorts !! Delhi Call Girls !! College Student Escorts !! Highclass Profile Escorts !! Connaught Place Escorts !! Saket Escorts !! Aerocity Escorts !! Mahipalpur Escorts !! Delhi Airport Escorts !! Dwarka Escorts !! Nehru Place Escorts !! Lajpat Nagar Escorts !! Karol Bagh Escorts !! Greater Kailash Escorts !! Paharganj Escorts !! Palam Vihar Escorts !! Rohini Escorts !! Gurgaon Escorts !! Noida Escorts !! Vasant Kunj Escorts !! South Ex Escorts !! Malviya Nagar Escorts !! Green Park Escorts !! Laxmi Nagar Call Girls !! Munirka Call Girls !! Punjabi Bagh Escorts !! Rajouri Garden Call Girls !! Surajkund Escorts !! Rajendra Place Escorts !! Barakhamba Road Escorts !! Patel Nagar Escorts !! Janpath Escorts !! Kirti Nagar Escorts !! Cyber City Escorts !! New Friends Colony Escorts !! Mayur Vihar Escorts !! Anand Vihar Escorts !! Shahdara Escorts !! Ashram Escorts !! Hotel Holiday Inn Gurgaon Escorts !! Delhi Night Club Escorts !! Hotel Trident Gurgaon Escorts !! Dipti Escorts !! Busty Escorts Delhi !! Kanak Tall Escorts !! Kanak Escorts !! Mahi Bdsm Escorts Delhi !! Mahi Escorts !! Bdsm Escorts Delhi !! Mitali Collage Girl Escorts Delhi !! Mitali Escorts !! Glamour Escorts Delhi !! Neharika Escorts !! Sadiya Escorts !! Sania Escorts !! Sarita Vihar Escorts !! Zara Escorts !! Aisha Escorts !! Ankita Escorts !! Ashley Escorts !! Delhi Escorts Agency !! Dania Escorts !! Hotel Royal Plaza Escorts !! Hotel The Lalit Escorts !! Hotel Hyatt Regency Escorts !! Hotel Taj Vivanta Escorts !! Hotel The Ashok Escorts !! Hotel Crowne Plaza Escorts !! Hotel Park Plaza Escorts !! Hotel Leela Escorts !! Hotel Eros Escorts !! Hotel Shangri La Escorts !! Hotel The Suryaa Escorts !! Hotel Novotel Escorts Service !! Hotel Pride Plaza Delhi Escorts !! Hotel The Roseate New Delhi Escorts !! Hotel Pullman Escorts Service !! Hotel Radisson Blu Escorts !! Hotel The Claridges Escorts !! Lesbian Escorts Delhi !! Mature Escorts In Delhi !! Delhi Hotel Escorts !! Massage Service In Delhi !! Hot Indian Desi Bhabhi Viral Sexy Video Photo !! Local Call Girls Near Me !! Online Randi Number With Photo !! Independent Escorts In Delhi !! Incall Outcall Delhi Escorts !! Dipti Busty Escorts !! Hotel Taj Mahal Escorts !! Hotel The Metropolitan Escorts !! Hotel Jw Marriott Escorts !! Hotel The Oberoi Escorts !! Hotel The Imperial Escorts !! Hotel Itc Maurya Escorts !! Hotel Samrat Escorts !! Escorts In Hyatt Place Gurgaon Udyog !! Hotel Radisson Gurgaon Udyog Vihar Escorts !! Hotel Taj City Center Gurugram Escorts !! Hotel The Palms Town Country Club Gurugram Escorts !! Hotel The Pllazio Escorts !! Escorts Service In Hotel Crowne Plaza Gurugram !! Escorts Service In Hotel The Leela Ambience Gurugram !! Escorts In Hotel Radisson Gurugram Sohna Road City Centre !! Escorts Service In Lemon Tree Hotel Gurgaon !! Hotel Golden Tulip Suites Gurgaon Escorts !! Hotel Hyatt Regency Gurgaon Escorts

An Arizona campaign that had been seeking to place an initiative on the ballot to repeal of key provisions of the state’s voter-approved marijuana legalization law has given up the effort. Under the “Sensible Marijuana Policy Act for Arizona” which was being spearheaded by Sean Noble, president of the political strategy firm American Encore, commercial recreational cannabis sales would have been eliminated while possession and personal cultivation would have continued to be legal. Noble, however, is no longer pursuing the measure, telling local media that he has “adjusted my viewpoints on the threat to kids” posed by the legal marijuana industry. He told Capitol Media Services that while he launched the campaign due to concerns about marketing of cannabis to children, he has come to realize that marijuana businesses in Arizona have “not done some of the things that I thought they were doing.” “I went into it with a pretty profound belief that it was happening,” Noble said. “I was kind of relying on things that I had seen or read from other people.” “I don’t think that they’re specifically marketing gummies and candies and that kind of thing the way that I was led to believe that they were doing,” he said. “Maybe they’re doing that in other states. But it’s not happening here in Arizona.” According to Capitol Media Services, Noble also came to realize that there wasn’t broad public support for rolling back marijuana legalization in the state, raising questions about whether the time and money that would go into such a campaign would end up being worth it. In January, two Republican members of Arizona’s U.S. House delegation spoke with Marijuana Moment about the proposed ballot measure to eliminate commercial cannabis sales in the state, voicing opposition to legalization. Rep. Paul Gosar (R-AZ) said he would like to see voters approve the rollback initiative. “We need to really take a comprehensive look at cannabis all the way across the board. Science tries to commit one way or another to us, and we’re not getting the full background on it,” he said, adding that he still regards marijuana as a “gateway drug” to other illicit substances and arguing that the cannabis industry has “resisted every which way with the regulations.” Rep. Andy Biggs (R-AZ) said that “the drug legalization movement kind of fails on me because of the social social construct and how much it costs us.” Meanwhile, this year has seen a series of attempts to scale back adult-use legalization laws. Anti-cannabis activists in Maine filed a ballot initiative to repeal state laws allowing recreational marijuana sales, but missed a deadline to turn in signatures for the 2026 ballot. A similar anti-cannabis measure in Massachusetts could potentially go before voters this year, but is currently subject to litigation. The Arizona measure was distinct from those proposals in at least one significant policy area: It would not have taken away the rights of adults to grow their own marijuana. Also, it would explicitly preserve components of the law aimed at expunging prior marijuana records. Like the anti-cannabis proposals in other states, possession would have remained lawful if the initiative were passed—and Arizona’s medical marijuana program would have remained intact—but the commercial market for recreational cannabis that’s evolved since voters approved an adult-use legalization measure in 2020 would have been quashed. A findings section of the initiative states that “the proliferation of marijuana establishments and recreational marijuana sales in this state have produced unintended consequences and negative effects relating to the public health, safety, and welfare of Arizonans, including increased marijuana use among children, environmental concerns, increased demands for water resources, public nuisances, market instability, and illicit market activities.” “Arizona’s legal marijuana sales have declined for two consecutive years, resulting in less tax revenue for this state, while some patients have relied on recreational use of marijuana instead of utilizing the benefits of this state’s medical marijuana program,” it says. “Sensible marijuana policy in this state requires a partial repeal of the Smart and Safe Act and authorization of the Arizona Legislature to make conforming changes to other Arizona laws, including those that relate to advertising requirements and taxation of marijuana and marijuana products, to effectuate the stated purposes and provisions of this Act.” The initiative would have also instructed the legislature to make conforming changes by amending existing statute regulating the commercial industry, including tax and advertising rules. In order to make the ballot, the campaign would have needed to collect 255,949 valid signatures by July 2. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Sixty percent of the Arizona electorate approved marijuana legalization at the ballot in 2020. A poll from last year found majority support for medical cannabis legalization (86 percent), adult-use legalization (69 percent) and banking reform (78 percent). Arizona lawmakers are considering legislation this session to penalize people who create “excessive” amounts of marijuana smoke or odor. The post Arizona Anti-Marijuana Campaign Drops Effort To Put Legalization Rollback On Ballot appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I’ve been surfing online more than 5 hours today, yet I never found any interesting article like yours without a doubt. It’s pretty worth enough for me. Thanks... Alexistogel